IgG4-Related Disease with Mandibular Mass and Cyst: A Case Report and Review of the Literature

Year 2022, Volume: 75 Issue: 4, 590 - 594, 20.01.2023

Mehmet Oğuz Yenidünya Betül Dumlu , Ülviye Yalçınkaya

Abstract

A 57 years old male patient came to our clinic with the complaint of limitation in mouth opening. There was a cystic tumor in his left mandible.
A surgical approach was planned for the cyst. During the operation in the region of the masseter muscle, somewhat abnormally rigid tissues were
observed. Three big tissue samples were taken from there. The histopathological diagnosis of the patient was reported as IgG4-related disease.
There-upon oral corticosteroid was started on the patient without any other surgery. The patient was under control for 2 years and he is fine. It was
wanted to be shared considering that it is very important to keep in mind the pathologies associated with IgG4, as it prevents the patient from an
unnecessary hemimandibulectomy.

Keywords

Mandibular Tumor , IgG4-Related Disease , Surgical Procedure , Steroid Treatment

Ethical Statement

-

Supporting Institution

-

Project Number

-

Thanks

-

Mandibular Kitle ve Kistin Eşlik Ettiği IgG4 ile İlişkili Hastalık: Bir Olgu Sunumu ve Literatürün Gözden Geçirilmesi

Abstract

Elli yedi yaşında erkek hasta kliniğimize ağız açmada kısıtlılık şikayetiyle başvurdu. Sol mandibulada kistik tümörü mevcuttu. Kist için cerrahi tedavi
planlandı. Ameliyat sırasında masseter kası bölgesinde anormal sert dokular dikkatimizi çekti. Oralardan 3 büyük doku örneği alındı. Hastanın
patolojik tanısı IgG4 ile ilişkili hastalık olarak geldi. Bunun üzerine hastaya daha başka bir cerrahi planlanmaksızın oral kortikosteroid başlandı. Hasta
iki yıldır kontrol altındadır ve iyidir. Hastanın gereksiz bir hemimandibulektomiye maruz kalmasının önüne geçtiği için IgG4 ile ilişkili patolojilerin
akılda tutulmasının çok önemli olduğu düşünülerek paylaşılmak istendi.

Keywords

Mandibuler Tümör , IgG4 İle İlişkili Hastalık , Cerrahi Tedavi , Steroid Tedavisi

Ethical Statement

-

Supporting Institution

-

Project Number

-

Thanks

-

References

• 1. Stone JH. IgG4-related disease: nomenclature, clinical features, and treatment. Semin Diagn Pathol. 2012;29:177-190.
• 2. Umehara H, Okazaki K, Masaki Y, et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol. 2012;22:1-14.
• 3. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732-738.
• 4. Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22:21-30.
• 5. Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet. 2015;11:1460-1471. [Epub ahead of print].
• 6. Inoue D, Yoshida K, Yoneda N, et al. IgG4-Related Disease: Dataset of 235 Consecutive Patients. Medicine (Baltimore). 2015;94:e680.
• 7. Karim F, Loeffen J, Bramer W, et al. IgG4-related disease: a systematic review of this unrecognized disease in pediatrics. Pediatr Rheumatol Online J. 2016;14:18.
• 8. Brito-Zerón P, Ramos-Casals M, Bosch X, et al. The clinical spectrum of IgG4-related disease. Autoimmun Rev. 2014;13:1203-1210.
• 9. Palazzo E, Palazzo C, Palazzo M. IgG4-related disease. Joint Bone Spine. 2014;81:27-31.
• 10. Karadeniz, H, Vaglio A. IgG4-related disease: a contemporary review. Turk J Med Sci. 2020;50:1616-1631.
• 11. Zen Y, Nakanuma Y. IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol. 2010;34:1812-1819.
• 12. Puxeddu I, Capecchi R, Carta F, et al. Salivary Gland Pathology in IgG4-Related Disease: A Comprehensive Review. J Immunol Res. 2018;6936727.
• 13. Yamamoto M, Takahashi H, Shinomura Y. Mechanisms and assessment of IgG4-related disease: lessons for the rheumatologist. Nat Rev Rheumatol. 2014;10:148-159.
• 14. Floreani A, Okazaki K, Uchida K, et al. IgG4-related disease: Changing epidemiology and new thoughts on a multisystem disease. J Transl Autoimmun. 2021;4:100074.
• 15. Della-Torre E, Feeney E, Deshpande V, et al. B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease. Ann Rheum Dis. 2014;74:2236-2243.
• 16. Kamisawa T, Okazaki K. Diagnosis and Treatment of IgG4-Related Disease. Curr Top Microbiol Immunol. 2017;401:19-33.
• 17. Khosroshahi A, Carruthers MN, Deshpande V, et al. Rituximab for the Treatment of IgG4-Related Disease Lessons From 10 Consecutive Patients. Medicine (Baltimore). 2012;91:57-66.